EU regulator backs GSK’s bone marrow cancer therapy – Reuters11/13/2023 majac Cancer … had recommended approving its oral therapy to treat anaemia in patients with a type of bone marrow cancer called myelofibrosis.Share on FacebookTweetFollow usSave